Profit and Loss Results Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2026 is -11.00% vs -20.89% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2026 is 56.19% vs -45.69% in Mar 2025
Interest
YoY Growth in year ended Mar 2026 is -35.33% vs 14.35% in Mar 2025
Profit After Tax
YoY Growth in year ended Mar 2026 is -25.15% vs -26.16% in Mar 2025
Compare Profit and Loss Results of Beryl Drugs
Figures in Cr
standalone - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
18.00
124.00
-106.00
-85.48%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
18.00
124.00
-106.00
-85.48%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
9.00
-9.00
-100.00%
Raw Materials Consumed
10.00
103.00
-93.00
-90.29%
Power & Fuel Cost
1.00
0.00
1.00
0%
Employee Cost
2.00
0.00
2.00
0%
Operating Expenses
2.00
0.00
2.00
0%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
0.00
0.00
0.00
0%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
0.00
0.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
16.00
121.00
-105.00
-86.78%
Operating Profit (PBDIT) excl Other Income
1.00
3.00
-2.00
-66.67%
Other Income
0.00
0.00
0.00
0%
Operating Profit (PBDIT)
2.00
3.00
-1.00
-33.33%
Interest
0.00
2.00
-2.00
-100.00%
Profit before Depriciation and Tax
2.00
1.00
1.00
100.00%
Depreciation
1.00
0.00
1.00
0%
Profit Before Taxation & Exceptional Items
0.00
1.00
-1.00
-100.00%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
0.00
1.00
-1.00
-100.00%
Provision for Tax
0.00
0.00
0.00
0%
Profit After Tax
0.00
0.00
0.00
0%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
4.00
2.00
2.00
100.00%
Profit Available for appropriations
4.00
3.00
1.00
33.33%
Appropriations
4.00
3.00
1.00
33.33%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
0.84
0.41
0.43
104.88%
Profit And Loss - Net Sales
Net Sales 18.82 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -11.00% vs -20.89% in Mar 2025
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 1.94 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 56.19% vs -45.69% in Mar 2025
Profit And Loss - Interest
Interest 0.35 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -35.33% vs 14.35% in Mar 2025
Profit And Loss - Profit After Tax
Profit After Tax 0.42 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -25.15% vs -26.16% in Mar 2025
Footer loading
